Cookies

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this repository, you give consent for essential cookies to be used. You can read more about our Privacy and Cookie Policy.


Durham Research Online
You are in:

Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost effective : economic analysis of the HELPUP trial.

Mason, J. M. and Raghunath, A. S. and Hungin, A. P. and Jackson, W. (2008) 'Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost effective : economic analysis of the HELPUP trial.', Alimentary pharmacology & therapeutics., 28 (11-12). pp. 1297-1303.

Abstract

Background Proton pump inhibitor (PPI) use is costly and about two-thirds of prescribing is long-term. Although 20–50% of patients may be infected with Helicobacter pylori, eradication is not normal clinical practice. Aim To establish if H. pylori eradication in long-term PPI users is cost-effective. Methods Long-term PPI-using patients (n = 183) testing positive for H. pylori were randomly assigned to true or placebo eradication therapy. Patients provided 2-year resource data, and 1-year symptom severity scores. A within-trial cost effectiveness analysis was conducted from a British health service perspective. Results Significant reductions in resource use occurred comparing eradication with placebo. After 2 years, PPI prescriptions (full-dose equivalents) fell by 3.9 (P < 0.0001); clinician (GP) consultations by 2.4 (P = 0.0001); upper gastrointestinal (GI) endoscopies by 14.8% (P = 0.008); clinician GI-related home visits by 19.9% (P = 0.005) and abdominal ultrasound scans fell by 20.3% (P = 0.005). Average net savings/patient were £93 (95% CI: 33–153) after costs of detection and eradication had been deducted. At 1 year, Leeds Dyspepsia Questionnaire symptoms fell by 3.1 (P = 0.005) and quality-of-life measures improved (EuroQol-5D: 0.089, P = 0.08; visual analogue scale: 5.6, P = 0.002) favouring eradication. Conclusion Helicobacter pylori eradication in infected, long-term PPI users is an economically dominant strategy, significantly reducing overall healthcare costs and symptom severity.

Item Type:Article
Full text:Full text not available from this repository.
Publisher Web site:http://dx.doi.org/10.1111/j.1365-2036.2008.03851.x
Record Created:27 Apr 2009 10:05
Last Modified:18 Aug 2011 10:34

Social bookmarking: del.icio.usConnoteaBibSonomyCiteULikeFacebookTwitterExport: EndNote, Zotero | BibTex
Usage statisticsLook up in GoogleScholar | Find in a UK Library